EPCAM and cancer: Yoshida et al. [167] synthesized an EpCAM-affinity coating agent consisting of a peptide aptamer for EpCAM and a zwitterionic poly-2-methacryloyloxyethyl phosphorylcholine polymer, allowing the concentration of cancer-related EVs from heterogeneous EV mixtures.